If you’ve heard about Medicare’s new GLP-1 Bridge Program, you may be wondering:
“Will Medicare pay for Wegovy® in 2026?”
The short answer is yes—but it depends on why you’re taking Wegovy and whether you meet the program’s eligibility requirements.
Let’s break down what Medicare currently covers, what changed in 2026, and how the Medicare GLP-1 Bridge Program may help eligible beneficiaries gain access to Wegovy for chronic weight management.
Medicare Coverage of Wegovy Before 2026
Historically, Medicare Part D has not covered medications prescribed solely for weight loss.
However, that changed for some patients when the U.S. Food and Drug Administration (FDA) approved Wegovy to reduce the risk of major cardiovascular events in certain adults with obesity or overweight and established cardiovascular disease.
As a result, some Medicare beneficiaries already qualify for Wegovy coverage through their regular Medicare Part D prescription drug benefit when prescribed for an FDA-approved cardiovascular indication.
What’s New in 2026?
Beginning in July 2026, CMS introduced the Medicare GLP-1 Bridge Program as part of the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) Model.
The demonstration program is designed to improve access to FDA-approved GLP-1 medications for eligible Medicare beneficiaries with obesity who previously had limited coverage options.
Under the program, eligible patients may obtain covered GLP-1 medications, including Wegovy, through a temporary payment model intended to expand access while CMS evaluates patient outcomes and healthcare costs.
Want to learn more about how the program works? Read our complete guide to the Medicare GLP-1 Bridge Program.
Who May Qualify?
Although CMS establishes the official eligibility requirements, patients generally must meet specific medical criteria before qualifying.
Eligibility may depend on factors such as:
- Body Mass Index (BMI)
- Obesity-related medical conditions
- Medical history
- Current medications
- Other CMS program requirements
Your healthcare provider can determine whether you meet the current eligibility criteria.
What If I Already Take Wegovy?
If you are already receiving Wegovy through your Medicare Part D prescription drug benefit for an FDA-approved cardiovascular indication, you generally would not receive the medication through the Medicare GLP-1 Bridge Program.
The Bridge Program was designed primarily to improve access for patients who otherwise would not have Medicare coverage for obesity treatment alone.
Because every patient’s situation is different, your healthcare provider can review your current coverage and determine which pathway applies to you.
What If I’m Taking Ozempic® Instead?
Many Medicare beneficiaries ask whether they can switch from Ozempic to Wegovy or qualify for the Bridge Program.
The answer depends on why Ozempic was prescribed.
If you currently receive Ozempic through Medicare for Type 2 diabetes, different Medicare coverage rules generally apply than for patients seeking obesity treatment.
For a detailed explanation, read our article:
Can I Get the Medicare GLP-1 Bridge Program If I Already Take Ozempic® for Type 2 Diabetes?
Why Is Medicare Expanding Access?
The decision to create the Medicare GLP-1 Bridge Program was driven by growing scientific evidence demonstrating that GLP-1 medications offer benefits beyond weight loss.
Large clinical trials have shown that appropriately selected patients may experience:
- Significant weight reduction
- Lower risk of heart attack
- Lower risk of stroke
- Improved blood pressure
- Better metabolic health
- Reduced inflammation
- Improved quality of life
These findings have changed how obesity is viewed—not simply as excess weight, but as a chronic disease that contributes to many serious medical conditions.
To learn more about the science behind the program, read:
What Is the Evidence Supporting the Medicare GLP-1 Bridge Program?
Frequently Asked Questions
Does Medicare Part D cover Wegovy?
It may. Medicare Part D may cover Wegovy for certain FDA-approved medical indications, such as cardiovascular risk reduction, depending on your specific situation and plan.
Will the Medicare GLP-1 Bridge Program pay for Wegovy?
Eligible beneficiaries who meet CMS program requirements may obtain Wegovy through the Medicare GLP-1 Bridge Program while the demonstration program is in effect.
Does everyone with obesity qualify?
No. Eligibility depends on CMS requirements and your individual medical history.
What if I have Medicare Advantage?
Patients enrolled in Medicare Advantage plans may still be eligible for the Medicare GLP-1 Bridge Program if they meet CMS eligibility requirements. However, coverage of office visits and provider network participation may depend on the specific Medicare Advantage plan. Your healthcare provider can help you understand how your plan applies to your situation.
How can I find out if I qualify?
The best way to determine your eligibility is to speak with a qualified healthcare provider who can review your medical history, current medications, and Medicare coverage.
Have Questions?
If you would like to learn whether you may qualify for the Medicare GLP-1 Bridge Program or have questions about Wegovy, GLP-1 medications, or medical weight management, we invite you to complete our secure Medical Weight Loss Inquiry Form. A member of the DPC Medical team will review your request, answer your questions, and discuss your treatment options. There is no obligation to schedule. Call us for information.
You may also visit our Contact Us page if you would like additional information or wish to speak with our office
Frequently Asked Questions
Does Medicare pay for Wegovy in 2026?
Yes, Medicare may pay for Wegovy in 2026, but coverage depends on why the medication is prescribed. Some beneficiaries qualify through their regular Medicare Part D benefit for FDA-approved indications, while others may qualify through the Medicare GLP-1 Bridge Program if they meet the program’s eligibility requirements.
Does the Medicare GLP-1 Bridge Program cover Wegovy?
The Medicare GLP-1 Bridge Program is designed to improve access to eligible GLP-1 medications, including Wegovy, for qualified Medicare beneficiaries receiving treatment for obesity. Eligibility is determined according to current CMS program requirements.
Is everyone with Medicare eligible for the Bridge Program?
No. Patients must meet specific clinical and program eligibility requirements established by CMS. Eligibility is determined on an individual basis after reviewing your medical history and current health conditions.
What if I already receive Wegovy through Medicare?
If your Wegovy prescription is already covered through your regular Medicare Part D benefit for an FDA-approved indication, such as cardiovascular risk reduction, you will generally continue receiving your medication through that benefit rather than through the Bridge Program.
Can I qualify if I take Ozempic® for Type 2 diabetes?
Patients receiving Ozempic® for Type 2 diabetes are generally covered through their regular Medicare Part D prescription drug benefit rather than the Medicare GLP-1 Bridge Program. Read our article, Can I Get the Medicare GLP-1 Bridge Program If I Already Take Ozempic® for Type 2 Diabetes?, to learn more.
Does Medicare Advantage cover Wegovy?
Patients enrolled in Medicare Advantage plans may still be eligible for the Medicare GLP-1 Bridge Program if they meet CMS eligibility requirements. However, office visit coverage and provider network participation depend on the specific Medicare Advantage plan.
Will Medicare cover Zepbound® instead of Wegovy?
Coverage depends on the specific FDA-approved indication, CMS program requirements, and your individual medical circumstances. As Medicare policies continue to evolve, discussing your options with your healthcare provider is the best way to determine which medication may be covered.
How do I find out if I qualify?
The best place to start is by completing our secure Medical Weight Loss Inquiry Form. A member of the DPC Medical– team will review your information, answer your questions, and discuss whether you may be a candidate for GLP-1 therapy.
Where can I learn more about the Medicare GLP-1 Bridge Program?
If you’re just getting started, we recommend reading these related articles: